Sign in

CIK 0001501989

  • Accelerated filer

CytomX Therapeutics, Inc.

Sign in to watch
Ticker
CTMX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
273521219
Phone
+1 650-515-3185
Business address
151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Open-market sale Chief Financial Officer sold 8,551 shares at $0.60 ($5,122)
  2. 4 Open-market sale Chief Medical Officer sold 4,025 shares at $0.60 ($2,411)
  3. 4 Open-market sale General Counsel sold 10,203 shares at $0.60 ($6,112)
  4. 4 Open-market sale SVP, Chief Scientific Officer sold 19,512 shares at $0.60 ($11,688)
  5. 4/A Grant or award SVP, Chief Scientific Officer acquired 92,500 shares (grant or award)
  6. 4 Grant or award SVP, Chief Scientific Officer acquired 87,500 shares (grant or award)
  7. 4 Grant or award Chief Medical Officer acquired 113,500 shares (grant or award)
  8. 4 Grant or award Chief Financial Officer acquired 101,500 shares (grant or award)
  9. 4 Grant or award CEO acquired 375,000 shares (grant or award)
  10. 4 Open-market sale Chief Business Officer sold 4,181 shares at $1.23 ($5,139)
  11. 4 Open-market sale SVP, Chief Scientific Officer sold 4,181 shares at $1.23 ($5,139)
  12. 4 Open-market sale General Counsel sold 4,181 shares at $1.23 ($5,139)
  13. 4 Open-market sale Chief Financial Officer sold 1,984 shares at $1.23 ($2,439)
  14. 4 Open-market sale CEO sold 13,898 shares at $1.23 ($17,082)
  15. 4 Grant or award Chief Financial Officer acquired 17,500 shares (grant or award)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 3 of 20 · 400 filings